Eric Grinstead
Geen lopende functies
Profiel
Eric Grinstead worked as an Associate Director and Senior Vice President in the pharmaceutical industry for companies such as Amgen, Genzyme Corp., Alexion Pharmaceuticals, and Synageva BioPharma Corp.
He also served as the Chief Commercial Officer for Clementia Pharmaceuticals.
Grinstead received his undergraduate degree from Westmont College.
Eerdere bekende functies van Eric Grinstead
Bedrijven | Functie | Einde |
---|---|---|
CLEMENTIA PHARMACEUTICALS INC | Corporate Officer/Principal | 30-11-2018 |
SYNAGEVA BIOPHARMA CORP | Corporate Officer/Principal | 01-01-2012 |
ALEXION PHARMACEUTICALS, INC. | General Counsel | 01-07-2009 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-09-2006 |
AMGEN INC. | Corporate Officer/Principal | 01-01-2005 |
Opleiding van Eric Grinstead
Westmont College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AMGEN INC. | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
Synageva BioPharma Corp.
Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA. | Health Technology |
Clementia Pharmaceuticals, Inc.
Clementia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Clementia Pharmaceuticals, Inc. provides healthcare services. It is a biopharmaceutical company, which focuses on exploiting the science of novel retinoic acid receptor gamma agonists to address bone disease and involves in development and commercialization of treatments for people living with rare diseases. Clementia Pharmaceuticals was founded by Clarissa Desjardins and Jean-Claude Tardif on November 5, 2010 and is headquartered in Montreal, Canada. | Health Technology |
Medical Marketing Economics LLC
Medical Marketing Economics LLC Miscellaneous Commercial ServicesCommercial Services Part of Indegene Ltd., Medical Marketing Economics LLC engages in value-based strategies and market research for health care goods and services. The private company is based in Oxford, MS. Medical Marketing Economics was acquired by Indegene Ltd. on August 30, 2021 for $10 million. The company was founded in 2001. The CEO is Jack M. Mycka. | Commercial Services |
The Safety Net Foundation |